EcoDrugPlus

Neuropeptide Y Receptor Y5

Ensembl ID : ENSLOCG00000018216
Gene Symbol: NPY5R
4 Cross references
135 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSLOCG00000005946
Gene Symbol: NTSR1
3 Cross references
210 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSLOCG00000000408
Gene Symbol: NTRK1
3 Cross references
199 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSLOCG00000014521
Gene Symbol: NTRK3
3 Cross references
269 Possible Orthologues:

Neurotrophic Tyrosine Kinase, Receptor, Type 2b

Ensembl ID : ENSLOCG00000002294
Gene Symbol: NTRK2B
1 Cross references
285 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2a

Ensembl ID : ENSLOCG00000006972
Gene Symbol: NFE2L2A
1 Cross references
216 Possible Orthologues:

Nicastrin

Ensembl ID : ENSLOCG00000001868
Gene Symbol: NCSTN
2 Cross references
203 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSLOCG00000015835
Gene Symbol: NAMPT
3 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSLOCG00000010609
Gene Symbol: NISCH
1 Cross references
209 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSLOCG00000005624
Gene Symbol: NOS2
3 Cross references
165 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSLOCG00000003419
Gene Symbol: NOTCH1
3 Cross references
267 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSLOCG00000007129
Gene Symbol: NOTCH3
1 Cross references
199 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).